For Healthcare Professionals

Congress Material

Boehringer Ingelheim is committed to pursuing leading science to develop transformative cancer treatments. Browse through our posters, presentations, and other materials shared during the latest oncology congress.

These Congress Materials were updated in May 2024 for the ESMO 2023 congress.

pipeline booklet

Clinical Assets Booklet

Learn more about our assets that are currently in clinical development in our oncology pipeline.

Pipeline Overview

Pipeline Overview

Gain an overview of our oncology pipeline, which includes cancer cell-directed compounds, immuno-oncology compounds and compounds targeting both cancer cells and immune cells.

Clinical trials

Ongoing Clinical Trials

Find a suitable clinical trial for your patient with this list of our ongoing studies in oncology.